Earn CME Credit & Prepare for the ABVM Certification

SVM Online Board Review Course

Learn more about CME credit*

Program Overview
The primary goal of the Comprehensive Review Course on Vascular and Endovascular Medicine program is to provide current treatment perspectives and management approaches on vascular disease, as well as expert background information, to SVM members and colleagues from related disciplines.

These courses will also prepare physicians for the American Board of Vascular Medicine certification examinations in general vascular medicine and endovascular interventions.

Courses include:

The Vascular System and Its Clinical and Laboratory Evaluation

  • Vascular Biology in 10 Minutes
  • The Comprehensive Vascular History and Physical Exam
  • The Basics of Arterial Laboratory Testing
  • Vascular Laboratory Basics: Venous Imaging

Peripheral Artery Disease

  • Epidemiology and Natural History of Peripheral Artery Disease
  • Medical Treatment of Peripheral Artery Disease: Antiplatelet and Statin Medications and Smoking Cessation
  • Acute Limb Ischemia
  • Deciding Between Endovascular & Open Revascularization
  • Endovascular Issues for Guidewires, Catheters, Balloons and Stents
  • Common Upper Extremity Arterial Disorders

Venous, Lymphatic and Thromboembolic Disease

  • ABCs of Venous Thromboembolism
  • Anticoagulation for Venous Thromboembolism
  • Prevention of Venous Thromboembolism and Perioperative Management
  • Thrombophilia Testing: When, Why and How
  • Advanced Therapies for Pulmonary Embolism
  • IVC Filters: Indications and Complications
  • Advanced Therapies for Acute DVT (upper and lower limbs): Including May-Thurner and Paget-Schroetter Syndrome
  • Chronic Venous Insufficiency
  • Endovenous Ablation: Thermal and Pharmacomechanical Options for Venous Disease
  • The Swollen Limb (including Lymphedema and Lipedema)

Cerebrovascular Disease

  • Stroke: Epidemiology and Risk Factors
  • Carotid, Subclavian and Vertebral Artery Disease: A Brief Review
  • Carotid Artery Disease: Surgical and Endovascular Options

The Aorta and Its Branches

  • Evaluation and Treatment of Renal Artery Disease
  • Endovascular Management of Abdominal Aortic Disease
  • Mesenteric Artery Disease: Diagnosis and Treatment
  • Endovascular Management of Thoracic Aortic Dissection

Special Topics

  • Preoperative and Postoperative Assessment of the Vascular Patient
  • Clinical Approach to Vasculitis
  • Lower Extremity Ulcers
  • Uncommon Vascular Disorders
  • Environmental Diseases: Erythromelalgia, Erythema Ab Igne, Pernio and Frostbite

Intended Audience
The Comprehensive Review Course is available for those who have clinical experience and formal training in vascular medicine, cardiology, radiology or surgery that includes the evaluation and management, both from the clinical and interventional perspective, of patients with peripheral vascular diseases. The goal is to allow these physicians to demonstrate expertise in the field.

The target audience includes those who seek certification in one or both areas or who are interested in a comprehensive review in the field of vascular and endovascular medicine.

The courses are also available to other medical professionals with an interest in vascular medicine or those who have a special interest in vascular disease or research therein. This may include graduate students, fellows, physician assistants, physician extenders, vascular nurses, nurse practitioners, vascular technologists, radiation technologists and other medical education specialists with an interest in vascular diseases.

Course Format
The course is delivered through a series of online videos with quiz questions following each one.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Amedco and Society for Vascular Medicine.
Amdeco is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement
Amedco designates this live activity for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

Course Co-Directors: John R. (Jerry) Bartholomew, MD, MSVM; Aditya Sharma, MBBS, RPVI, FSVM; Bruce H. Gray, DO, MSVM; Steven Dean, DO, FSVM

Release Date: October 15, 2016

Termination Date: December 31, 2018 (After this date, CME credit for this enduring material is no longer available unless it has been re-issued for an additional time period.)

CME Registration
To receive CME credit for the Vascular and Endovascular Review Courses, you must:

  • Purchase a course or courses.
  • Listen to the presentation and view the slides.
  • Click on the associated quiz.
  • Complete the quiz.
  • Upon completion of the quiz, you will be able to print a certificate of completion.
  • These review courses are meant to be used as a self-assessment tool for physicians to identify knowledge gaps.

Learning Objectives
At the conclusion of this activity, participants should be able to:

  • Describe and implement current aspects of evaluation and management of peripheral vascular disorders, including arterial, venous, lymphatic disorders; hypercoagulability; environmental and occupational vascular disorders; and the interaction between vascular and cardiac disorders.
  • Demonstrate expertise in the endovascular and surgical options for patients with vascular disease.
  • Explain the comprehensive background information to prepare for the vascular general and/or the endovascular general examination(s) for certification.

Amedco asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Amedco and the Society for Vascular Medicine have procedures to resolve apparent conflicts of interest. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceuticals and devices is being discussed. See the full disclosure policy and faculty disclosures below.

To Purchase Online
Members: Click here to purchase at the discount member rate.


  • Purchase the course here.
  • Or join SVM and receive discounted member rates.
Comprehensive Vascular and Endovascular Review Course
Complete course 6.5 hours
Member $350 Nonmember $440

The Vascular System and Its Clinical and Laboratory Evaluation
1 hour
Member $60 Nonmember $75

Peripheral Artery Disease
1.25 hours
Member $75 Nonmember $94

Venous, Lymphatic and Thromboembolic Disease
2 hours
Member $120 Nonmember $150

Cerebrovascular Disease and the Aorta and Its Branches
1.25 hour
Member $75 Nonmember $94

Special Topics
1 hour
Member $60 Nonmember $75


Disclosure Policy

It is the policy of Amedco to ensure balance, independence, objectivity and scientific rigor in all of its sponsored educational activities. All participating speakers, course directors and planning committee members are required to disclose to the program audience any financial relationships related to the subject matter of this program. Relationships of spouse/partner with proprietary entities producing health care goods or services should be disclosed if they are of a nature that may influence the objectivity of the individual in a position to control the content of the CME activity. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest.

In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. Specific disclosure information for each speaker, course director and planning committee member will be shared with the audience prior to the speaker’s presentation.

It is understood that presentations must give a balanced view of therapeutic options. Faculty use of generic names will contribute to this impartiality. The speaker shall every effort to ensure that data regarding the company’s products (or competing products) are objectively selected and presented, with balanced discussion of prevailing information on the product(s) and/or alternative treatments.

Amedco requires faculty and members of the Scientific Program Committee to disclose whether or not they have any relevant commercial relationships or if they will be discussing unlabeled and/or investigational uses of any products, pharmaceuticals or medical devices. This must be made known in advance to the audience in accordance with the ACCME Standards of Commercial Support guidelines.

Financial Disclosures
The following faculty and members of the planning committee indicated that they have financial relationships to disclose. They have agreed to disclose this to participants. All other named faculty and committee members in this program have completed financial disclosure forms and had no financial relationships to report.

Ehrin Armstrong

Abbott Vascular - Consulting - Not Relevant, Medtronic - Consulting - Not Relevant, Merck - Advisory Board - Not Relevant, Spectranetics - Consulting - Not Relevant

J. Michael Bacharach

Boston Scientific - Speakers Bureau - Not Relevant, Bristol Myers Squibb - Speakers Bureau - Not Relevant, Cook Medical - Speakers Bureau - Not Relevant, IAC - Board Member - Not Relevant, W. L. Gore & Associates - Consultant & Speakers Bureau - Not Relevant

Geoffrey Barnes

Grant/Research Support - BMS/Pfizer, Blue Cross Blue Shield of Michigan Consultant - Portola

John Bartholomew

Consultant For Sanyko Daiichi

Joshua Beckman

Merck, Bms, Astra Zeneca: Consultant, Bms, Merck: Investigator Initiated Research, Bayer: Dsmb

Steve Dean

Scientific Advisory Board - Tactile Medical

Heather Gornik

Site Research - Astrazeneca Euclid Trial, Non Compensated Board Member - Intersocietal Accreditation Commission -Vascular Testing

Naomi Hamburg

Acceleron Pharma - Husband is General Counsel

William Hiatt

Grant/Research Support - Bayer, Grant/Research Support - Astrazeneca, Grant/Research Support - CSI, Grant/Research Support - Celgene, Grant/Research Support - Pluristem

Alan Hirsch

Research Grants: NHLBI; Astrazeneca; Pluristem (All Relevant For PAD); Consulting: Merck, Novartis, Bayer (All Relevant For PAD); Consulting and Chief Medical Officer, Tactile Medical (Relevant For Lymphedema and Venous Insufficiency)

Esther S.H. Kim

Consultant, Philips Ultrasound - Relevant

Raghu Kolluri

Bard - Dsmb; Medtronic - Consultant; Volcano - Consultant; Boston Scientific - Consultant.

Carol Langford

Bristol-Myers Squibb Grant/Research Support, Glaxosmithkline Grant/Research Support, Genentech Grant/Research Support

Geno Merli

Bms, J&J, Sanofi-Aventis, Portola, Janssen Scientific Affairs - Grant/Research Support, Bms, J&J, Sanofi Aventis - Scientific Consultant

Gregory Piazza

Daiichi Sankyo- Research Grant, Janssen- Research Grant, EKOS/BTG- Research Grant, BMS- Research Grant, Exithera- Consulting, Zafgen- Consulting, Merck- Consulting

Thom Rooke

Osborn -- Royalty -- Not Relevant

Aditya Sharma

Grant / Research Support - NIH / Astra Zeneca/ Portola Pharmaceutical / Biomet

Mitchell Silver

Bristol Myers Squibb-Speaker Bureau - NR, Pfizer-Speaker Bureau- NR, Boston Scientific-Consultant - NR, Gore Medica l- Consultant- NR, Medtronic- Consultant- NR, Contego Medical-Shareholder- NR, Endologix-Shareholder- NR

Unlabeled/Investigational Uses Disclosures

Amedco requires that faculty members disclose when any discussion of unapproved use of pharmaceuticals and devices takes place. The following faculty have reported that they plan to discuss unlabeled or investigational uses of a drug or device.

Herbert Aronow

Stents in PAD

Society for Vascular Medicine
17W110 22nd Street, Suite 800
Oakbrook Terrace, IL 60181 USA

Tweets by SVM_tweets